Characterization of a xenograft model for anti-CD19 CAR T cell studies
Author:
Funder
Tehran University of Medical Sciences
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s12094-021-02626-5.pdf
Reference33 articles.
1. Srivastava S, Riddell SR, Alerts E. Chimeric antigen receptor T cell therapy: challenges to bench-to-bedside efficacy. J Immunol. 2018;200(2):459–68. https://doi.org/10.4049/jimmunol.1701155.
2. Martinez M. Moon E K (2019) CAR T cells for solid tumors: new strategies for finding, infiltrating, and surviving in the tumor microenvironment. Front Immunol. 2019;10:128. https://doi.org/10.3389/fimmu.2019.00128.
3. Miranda A, Marion F, Ariana P, Rafael Z, Gragera M, Steliarova E, et al. Global patterns and trends in the incidence of non-Hodgkin lymphoma. Cancer Causes Control. 2019;30(5):489–99. https://doi.org/10.1007/s10552-019-01155-5.
4. Hopfinger G, Jäger U, Worel N, Worel CN. CAR-T cell therapy in diffuse large B cell lymphoma: hype and hope. Hemasphere. 2019;3(2):e185. https://doi.org/10.1097/HS9.0000000000000185.
5. Kalaitsidou M, Gilham DE. CAR T-cell therapy : toxicity and the relevance of preclinical models. Immunotherapy. 2015;7(5):487–97. https://doi.org/10.2217/imt.14.123.
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Release Assays and Potency Assays for CAR T-Cell Interventions;Potency Assays for Advanced Stem Cell Therapy Medicinal Products;2023
2. Personalized Immuno-Oncology with Immunodeficiency Mouse Models;Interdisciplinary Cancer Research;2023
3. In Vitro Diffuse Large B-Cell Lymphoma Cell Line Models as Tools to Investigate Novel Immunotherapeutic Strategies;Cancers;2022-12-30
4. Adoptive NK‐cell transfer as a potential treatment paradigm for Wilms tumor: A preclinical study;Pediatric Blood & Cancer;2022-04-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3